心血管治疗药物综述

上传人:大米 文档编号:578884467 上传时间:2024-08-25 格式:PPT 页数:82 大小:2.81MB
返回 下载 相关 举报
心血管治疗药物综述_第1页
第1页 / 共82页
心血管治疗药物综述_第2页
第2页 / 共82页
心血管治疗药物综述_第3页
第3页 / 共82页
心血管治疗药物综述_第4页
第4页 / 共82页
心血管治疗药物综述_第5页
第5页 / 共82页
点击查看更多>>
资源描述

《心血管治疗药物综述》由会员分享,可在线阅读,更多相关《心血管治疗药物综述(82页珍藏版)》请在金锄头文库上搜索。

1、PharmacologyDrugs that Affect the Cardiovascular SystemTopicsElectrophysiologyVaughn-Williams classificationAntihypertensivesHemostatic agentsCardiac FunctionDependent uponAdequate amounts of ATPAdequate amounts of Ca+Coordinated electrical stimulusAdequate Amounts of ATPNeeded to:Maintain electroch

2、emical gradientsPropagate action potentialsPower muscle contractionAdequate Amounts of CalciumCalcium is glue that links electrical and mechanical events.Coordinated Electrical StimulationHeart capable of automaticityTwo types of myocardial tissueContractileConductiveImpulses travel through action p

3、otential superhighway.A.P. SuperHighwaySinoatrial nodeAtrioventricular nodeBundle of HisBundle BranchesFasciclesPurkinje NetworkElectrophysiologyTwo types of action potentialsFast potentialsFound in contractile tissueSlow potentialsFound in SA, AV node tissuesFast Potential-80-60-40-200+20RMP-80 to

4、90 mVPhase 1Phase 2Phase 3Phase 4controlled by Na+channels = “fast channels”Fast PotentialPhase 0: Na+ influx “fast sodium channels”Phase 1: K + effluxPhase 2: (Plateau) K + efflux AND Ca + + influxPhase 3: K+ effluxPhase 4: Resting Membrane PotentialCardiac Conduction CycleSlow Potential-80-60-40-2

5、00Phase 4Phase 3dependent upon Ca+ channels = “slow channels”Slow PotentialSelf-depolarizingResponsible for automaticityPhase 4 depolarizationslow sodium-calcium channelsleaky to sodiumPhase 3 repolarizationK+ effluxCardiac Pacemaker DominanceIntrinsic firing rates:SA = 60 100 AV = 45 60Purkinje = 1

6、5 - 45Cardiac PacemakersSA is primaryFaster depolarization rateFaster Ca+ leakOthers are backupsGraduated depolarization rateGraduated Ca+ leak ratePotential TermsAPDERPRRPrelative refractoryperiodeffective refractory periodaction potential durationDysrhythmia GenerationAbnormal genesisImbalance of

7、ANS stimuliPathologic phase 4 depolarizationEctopic fociDysrhythmia GenerationAbnormal conductionAnalogies:One way valveBuggies stuck in muddy roadsReentrant CircuitsWarning!All antidysrhythmics have arrythmogenic propertiesIn other words, they all can CAUSE dysrhythmias too!AHA Recommendation Class

8、ificationsDescribes weight of supporting evidence NOT mechanismClass IClass IIaClass IIb IndeterminantClass IIIView AHA definitionsVaughn-Williams ClassificationClass 1IaIbIcClass IIClass IIIClass IVMiscDescription of mechanism NOT evidenceClass I: Sodium Channel BlockersDecrease Na+ movement in pha

9、ses 0 and 4Decreases rate of propagation (conduction) via tissue with fast potential (Purkinje)Ignores those with slow potential (SA/AV)Indications: ventricular dysrhythmiasClass Ia AgentsSlow conduction through ventriclesDecrease repolarization rateWiden QRS and QT intervalsMay promote Torsades des

10、 Pointes!PDQ:procainamide (Pronestyl)disopyramide (Norpace)qunidine (Quinidex)Class Ib AgentsSlow conduction through ventriclesIncrease rate of repolarizationReduce automaticityEffective for ectopic fociMay have other usesLTMD:lidocaine (Xylocaine)tocainide (Tonocard)mexiletine (Mexitil)phenytoin (D

11、ilantin)Class Ic AgentsSlow conduction through ventricles, atria & conduction systemDecrease repolarization rateDecrease contractilityRare last chance drugflecainide (Tambocor)propafenone (Rythmol)Class II: Beta BlockersBeta1 receptors in heart attached to Ca+ channelsGradual Ca+ influx responsible

12、for automaticityBeta1 blockade decreases Ca+ influxEffects similar to Class IV (Ca+ channel blockers)Limited # approved for tachycardiasClass II: Beta Blockerspropranolol (Inderal)acebutolol (Sectral)esmolol (Brevibloc)Class III: Potassium Channel BlockersDecreases K+ efflux during repolarizationPro

13、longs repolarizationExtends effective refractory periodPrototype: bretyllium tosylate (Bretylol)Initial norepi discharge may cause temporary hypertension/tachycardiaSubsequent norepi depletion may cause hypotensionClass IV: Calcium Channel BlockersSimilar effect as blockersDecrease SA/AV automaticit

14、yDecrease AV conductivityUseful in breaking reentrant circuitPrime side effect: hypotension & bradycardiaverapamil (Calan)diltiazem (Cardizem)Note: nifedipine doesnt work on heartMisc. Agentsadenosine (Adenocard)Decreases Ca+ influx & increases K+ efflux via 2nd messenger pathwayHyperpolarization of

15、 membraneDecreased conduction velocity via slow potentialsNo effect on fast potentialsProfound side effects possible (but short-lived)Misc. AgentsCardiac Glycocidesdigoxin (Lanoxin)Inhibits NaKATP pumpIncreases intracellular Ca+via Na+-Ca+ exchange pumpIncreases contractilityDecreases AV conduction

16、velocityPharmacologyAntihypertensivesAntihypertensive Classesdiureticsbeta blockersangiotensin-converting enzyme (ACE) inhibitors calcium channel blockersvasodilatorsBlood Pressure = CO X PVRCardiac Output = SV x HRPVR = AfterloadBP = CO x PVRKey:CCB = calcium channel blockersCA Adrenergics = centra

17、l-acting adrenergicsACEis = angiotensin-converting enzyme inhibitorscardiac factorscirculating volumeheart ratecontractility1. Beta Blockers2. CCBs3. C.A. AdrenergicssaltaldosteroneACEisDiureticsBP = CO x PVRHormones1. vasodilators2. ACEIs3. CCBs Central Nervous System1. CA AdrenergicsPeripheral Sym

18、patheticReceptorsalpha beta1. alpha blockers 2. beta blockersLocal Acting1. Peripheral-Acting AdrenergicsAlpha1 BlockersStimulate alpha1 receptors - hypertensionBlock alpha1 receptors - hypotensiondoxazosin (Cardura)prazosin (Minipress)terazosin (Hytrin)Central Acting AdrenergicsStimulate alpha2 rec

19、eptors inhibit alpha1 stimulationhypotensionclonidine (Catapress)methyldopa (Aldomet)Peripheral Acting Adrenergicsreserpine (Serpalan)inhibits the release of NEdiminishes NE storesleads to hypotensionProminent side effect of depressionalso diminishes seratoninAdrenergic Side EffectsCommondry mouth,

20、drowsiness, sedation & constipationorthostatic hypotensionLess commonheadache, sleep disturbances, nausea, rash & palpitationsAngiotensin IACEAngiotensin II1.1. potent vasoconstrictor- increases BP2. stimulates Aldosterone- Na+ & H2OreabsorbtionACE Inhibitors .RAASRenin-Angiotensin Aldosterone Syste

21、mAngiotensin II = vasoconstrictorConstricts blood vessels & increases BPIncreases SVR or afterloadACE-I blocks these effects decreasing SVR & afterloadACE InhibitorsAldosterone secreted from adrenal glands cause sodium & water reabsorptionIncrease blood volumeIncrease preloadACE-I blocks this and de

22、creases preloadAngiotensin Converting Enzyme Inhibitorscaptopril (Capoten)enalapril (Vasotec)lisinopril (Prinivil & Zestril)quinapril (Accupril)ramipril (Altace)benazepril (Lotensin)fosinopril (Monopril)Calcium Channel BlockersUsed for:AnginaTachycardiasHypertensionCCB Site of Actiondiltiazem & vera

23、pamilnifedipine (and otherdihydropyridines)CCB Actiondiltiazem & verapamildecrease automaticity & conduction in SA & AV nodesdecrease myocardial contractilitydecreased smooth muscle tonedecreased PVRnifedipinedecreased smooth muscle tonedecreased PVRSide Effects of CCBsCardiovascularhypotension, pal

24、pitations & tachycardiaGastrointestinalconstipation & nauseaOtherrash, flushing & peripheral edemaCalcium Channel Blockersdiltiazem (Cardizem)verapamil (Calan, Isoptin)nifedipine (Procardia, Adalat)Diuretic Site of Action.loop of HenleproximaltubuleDistal tubuleCollecting ductMechanismWater follows

25、Na+20-25% of all Na+ is reabsorbed into the blood stream in the loop of Henle5-10% in distal tubule & 3% in collecting ductsIf it can not be absorbed it is excreted with the urine Blood volume = preload !Side Effects of Diureticselectrolyte losses Na+ & K+ fluid losses dehydrationmyalgiaN/V/Ddizzine

26、sshyperglycemiaDiureticsThiazides:chlorothiazide (Diuril) & hydrochlorothiazide (HCTZ, HydroDIURIL)Loop Diureticsfurosemide (Lasix), bumetanide (Bumex)Potassium Sparing Diureticsspironolactone (Aldactone)Mechanism of VasodilatorsDirectly relaxes arteriole smooth muscleDecrease SVR = decrease afterlo

27、ad Side Effects of Vasodilatorshydralazine (Apresoline)Reflex tachycardiasodium nitroprusside (Nipride)Cyanide toxicity in renal failureCNS toxicity = agitation, hallucinations, etc.Vasodilatorsdiazoxide Hyperstathydralazine Apresolineminoxidil Lonitensodium Nitroprusside NipridePharmacologyDrugs Af

28、fecting HemostasisHemostasisReproduce figure 11-9, page 359 Sherwood Platelet AdhesionCoagulation CascadeReproduce following components of cascade:Prothrombin - thrombin Fibrinogen - fibrinPlasminogen - plasminPlatelet InhibitorsInhibit the aggregation of plateletsIndicated in progressing MI, TIA/CV

29、ASide Effects: uncontrolled bleedingNo effect on existing thrombi AspirinInhibits COXArachidonic acid (COX) - TXA2 ( aggregation)GP IIB/IIIA InhibitorsGPGP IIIIb b/ /IIIIIIa aInhibitorsInhibitorsFibrinogenGPGP IIIIb b/ /IIIIIIa aReceptorReceptorGP IIB/IIIA Inhibitorsabciximab (ReoPro)eptifibitide (I

30、ntegrilin)tirofiban (Aggrastat)AnticoagulantsInterrupt clotting cascade at various pointsNo effect on plateletsHeparin & LMW Heparin (Lovenox)warfarin (Coumadin)HeparinEndogenousReleased from mast cells/basophilsBinds with antithrombin IIIAntithrombin III binds with and inactivates excess thrombin t

31、o regionalize clotting activity.Most thrombin (80-95%) captured in fibrin mesh.Antithrombin-heparin complex 1000X as effective as antithrombin III aloneHeparinMeasured in Units, not milligramsIndications:MI, PE, DVT, ischemic CVAAntidote for heparin OD: protamine.MOA: heparin is strongly negatively

32、charged. Protamine is strongly positively charged. warfarin (Coumadin)Factors II, VII, IX and X all vitamin K dependent enzymesWarfarin competes with vitamin K in the synthesis of these enzymes.Depletes the reserves of clotting factors.Delayed onset (12 hours) due to existing factorsThrombolyticsDir

33、ectly break up clotsPromote natural thrombolysisEnhance activation of plasminogenTime is Musclestreptokinase (Streptase)alteplase (tPA, Activase)anistreplase (Eminase)reteplase (Retevase)tenecteplase (TNKase)Occlusion MechanismtPA MechanismCholesterol MetabolismCholesterol important component in mem

34、branes and as hormone precursorSynthesized in liverHydroxymethylglutaryl coenzyme A reductase(HMG CoA reductase) dependantStored in tissues for latter useInsoluble in plasma (a type of lipid)Must have transport mechanismLipoproteinsLipids are surrounded by protein coat to hide hydrophobic fatty core

35、.Lipoproteins described by densityVLDL, LDL, IDL, HDL, VHDLLDL contain most cholesterol in bodyTransport cholesterol from liver to tissues for use (“Bad”)HDL move cholesterol back to liver“Good” b/c remove cholesterol from circulationWhy We Fear CholesterolRisk of CAD linked to LDL levelsLDLs are de

36、posited under endothelial surface and oxidized where they:Attracts monocytes - macrophagesMacrophages engulf oxidized LDLVacuolation into foam cellsFoam cells protrude against intimal liningEventually a tough cap is formedVascular diameter & blood flow decreasedWhy We Fear CholesterolPlaque cap can

37、ruptureCollagen exposedClotting cascade activatedPlatelet adhesionThrombus formationEmbolus formation possibleOcclusion causes ischemiaLipid DepositionThrombus FormationPlatelet AdhesionEmbolus FormationOcclusion Causes InfarctionAntihyperlipidemic AgentsGoal: Decrease LDLInhibition of LDL synthesisIncrease LDL receptors in liverTarget: 200 mg/dlStatins are HMG CoA reductase inhibitorslovastatin (Mevacor)pravastatin (Pravachol)simvastatin (Zocor)atorvastatin (Lipitor)

展开阅读全文
相关资源
正为您匹配相似的精品文档
相关搜索

最新文档


当前位置:首页 > 高等教育 > 研究生课件

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号